Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia

66Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To further our understanding of the genetic basis of acute myelogenous leukemia (AML), we determined the coding exon sequences of ∼18 000 protein-encoding genes in 8 patients with secondary AML. Here we report the discovery of novel somatic mutations in the transcriptional corepressor gene BCORL1 that is located on the X-chromosome. Analysis of BCORL1 in an unselected cohort of 173 AML patients identified a total of 10 mutated cases (6%) with BCORL1 mutations, whereas analysis of 19 AML cell lines uncovered 4 (21%) BCORL1 mutated cell lines. The majority (87%) of the mutations in BCORL1 were predicted to inactivate the gene product as a result of nonsense mutations, splice site mutation, or out-of-frame insertions or deletions. These results indicate that BCORL1 by genetic criteria is a novel candidate tumor suppressor gene, joining the growing list of genes recurrently mutated inAML. © 2011 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Li, M., Collins, R., Jiao, Y., Ouillette, P., Bixby, D., Erba, H., … Malek, S. N. (2011). Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia. Blood, 118(22), 5914–5917. https://doi.org/10.1182/blood-2011-05-356204

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free